TITLE

Qutenza

PUB. DATE
January 2010
SOURCE
Pharmaceutical Representative;Jan2010, Vol. 40 Issue 1, p11
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the approval of Qutenza, a medicated skin patch for the pain of post-herpetic neuralgia, by the Food and Drug Administration (FDA) in the U.S.
ACCESSION #
51017074

 

Related Articles

  • Smaller size, lower-dose testosterone patch gets FDA nod.  // Urology Times;Dec2011, Vol. 39 Issue 13, p37 

    The article reports the approval of U.S. Food and Drug Administration (FDA) on Watson Pharmaceuticals Inc.'s lower-dose formulation testosterone transdermal system (Androderm),

  • FDA actions in brief.  // Formulary;Mar2006, Vol. 41 Issue 3, p111 

    The article offers U.S. Food and Drug Administration drug approval developments. Hepatitis B immune globulin was approved for the treatment of acute exposure to blood having the hepatitis B surface antigen. Rituximab was approved as a first-line treatment for diffuse large B-cell, CD20-positive...

  • FDA approvals.  // Clinical Oncology Alert;Jul2007, Vol. 23 Issue 7, p2 

    This section offers news briefs on drug approvals of the U.S. Food and Drug Administration (FDA). Included in these drugs is the rotigotine transdermal for the treatment of early stage idiopathic Parkinson's disease. A new continuous contraceptive for women aimed to eliminate menstruation has...

  • FDA approvals. Elliott, William T. // Clinical Oncology Alert;Jul2007 Pharmacology Watch, p2 

    The section offers updates from several U.S. Food and Drug Administration (FDA) approvals as of July 2007. A new transdermal patch was approved by FDA for the treatment of early stage idiopathic Parkinson's disease. A continuous contraceptive for women was also approved by FDA, which is designed...

  • FDA approves first Parkinson's patch. Thompson, Cheryl A. // American Journal of Health-System Pharmacy;6/15/2007, Vol. 64 Issue 12, p1244 

    The article reports on the approval of the market­ing of Neupro, a transdermal system by Schwarz Pharma that continuously delivers rotigotine, a "non-ergolinic" dopamine-receptor agonist by the Food and Drug Administration (FDA) in the U.S. Dizziness, nausea, vomiting, drowsiness, insomnia,...

  • Vivus Reaps Evamist Approval, $140M.  // Bioworld Week;8/6/2007, Vol. 15 Issue 32, p2 

    The article reports on the success of Mountain View, California-based pharmaceutical company Vivus Inc. to win the U.S. Food and Drug Administration (FDA) approval of its Evamist product, which lead the company to acquire $140 million partnership payment. The FDA approved the product, a...

  • GENERICS NEWSLINE.  // Monthly Prescribing Reference;Oct2015, Vol. 31 Issue 10, pA10 

    The article offers news briefs related to medicine as of October 1, 2015. Topics discussed include the launch of piperacillin and tazobactam for injection from the pharmaceuticals company Mylan NV, the Food and Drug Administration (FDA) has approved the use of the mucinex maximum strength and...

  • SHIRE GETS FDA APPROVABLE LETTER FOR DAYTRANA FOR ADHD.  // Worldwide Biotech;Feb2006, Vol. 18 Issue 2, p3 

    Reports on the approval given by the U.S. Food and Drug Administration to DAYTRANA, an investigational methylphenidate transdermal system developed by Shire PLC. Use of the drug for treating attention deficit hyperactivity disorder (ADHD) in children; Remarks from company CEO Matthew Emmens...

  • Placebo Effect of Transdermal NSAIDs. Ondarza, Adrianne; Lewis, Frederick; Womack, Tony // Applied Clinical Trials;Jun2011, Vol. 20 Issue 6, p52 

    The article offers information on the placebo effect of transdermal nonsteroidal anti-inflammatory drugs (NSAIDs). It states that the U.S. Food and Drug Administration (FDA) has approved some transdermal NSAID products in the country, especially King's product Flector or diclofenac which is an...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics